159 related articles for article (PubMed ID: 32355768)
21. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
22. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
[TBL] [Abstract][Full Text] [Related]
23. Identification of Prognosis-Related RNA-Binding Proteins to Reveal the Role of RNA-Binding Proteins in the Progression and Prognosis of Colon Cancer.
Ding Y; Fang L; Yang XP; Zou Q
Int J Gen Med; 2021; 14():6795-6805. PubMed ID: 34703285
[TBL] [Abstract][Full Text] [Related]
24. Development of Potential Prognostic Biomarkers Based on DNA Methylation-Driven Genes for Patients with Endometrial Cancer.
Lu Y; Tang W; Wang X; Kang X; You J; Chen L
Int J Gen Med; 2021; 14():10541-10555. PubMed ID: 35002309
[TBL] [Abstract][Full Text] [Related]
25. Screening of key methylation-driven genes CDO1 in breast cancer based on WGCNA.
Tu S; Zhang H; Qu X
Cancer Biomark; 2022; 34(4):571-582. PubMed ID: 35342080
[TBL] [Abstract][Full Text] [Related]
26. A six-gene prognostic model predicts overall survival in bladder cancer patients.
Wang L; Shi J; Huang Y; Liu S; Zhang J; Ding H; Yang J; Chen Z
Cancer Cell Int; 2019; 19():229. PubMed ID: 31516386
[TBL] [Abstract][Full Text] [Related]
27. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
28. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
29. Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database.
Feng L; Jin F
Oncol Lett; 2018 Nov; 16(5):6407-6416. PubMed ID: 30405777
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
31. Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
Luo Y; Sun F; Peng X; Dong D; Ou W; Xie Y; Luo Y
Int J Gen Med; 2021; 14():4745-4756. PubMed ID: 34466019
[TBL] [Abstract][Full Text] [Related]
32. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer.
Li Y; Mo N; Yang D; Lin Q; Huang W; Wang R
Front Oncol; 2023; 13():1238310. PubMed ID: 37771430
[TBL] [Abstract][Full Text] [Related]
34. Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis.
Zhong X; Zhong G
FEBS Open Bio; 2021 Aug; 11(8):2139-2151. PubMed ID: 34056873
[TBL] [Abstract][Full Text] [Related]
35. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
36. A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
Cheng Q; Huang C; Cao H; Lin J; Gong X; Li J; Chen Y; Tian Z; Fang Z; Huang J
Front Genet; 2019; 10():906. PubMed ID: 31632439
[No Abstract] [Full Text] [Related]
37. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Tang H; Kan L; Ou T; Chen D; Dou X; Wu W; Ji X; Wang M; Zong Z; Mo H; Zhang X; Xiong D
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441304
[TBL] [Abstract][Full Text] [Related]
39. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.
Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
Front Immunol; 2022; 13():803962. PubMed ID: 35222383
[TBL] [Abstract][Full Text] [Related]
40. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
Front Oncol; 2020; 10():556018. PubMed ID: 33134164
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]